Hospitalization among vaccines for SARS-CoV-2 breakthrough infection after dose sparing strategies in Libya: A cohort study.

Abdelhamid, Mohamed Hadi Mohamed; Almsellati, Iman Amin; Annajar, Badereddin B; Abdulhamid, Alaa H; Alemam, Hafsa; Etikar, Mohammed

Abdelhamid, Mohamed Hadi Mohamed; Almsellati, Iman Amin; Annajar, Badereddin B; Abdulhamid, Alaa H; Alemam, Hafsa; Etikar, Mohammed.

Afiliação

Abdelhamid MHM; Head of Researchs and Sciences Committees Office, National Center for Disease Control (NCDC), Tripoli, Libya.
Almsellati IA; Department of Cell Biology and Tissue Culture, Libyan Biotechnology Research Center (BTRC), Tripoli, Libya.
Annajar BB; Primary Health Care, National Center of Disease Control (NCDC), Tripoli, Libya.
Abdulhamid AH; Department of Public Health, Faculty of Medical Technology, University of Tripoli, Tripoli, Libya.
Alemam H; Department of Cardiology, Tripoli University Hospital, Tripoli, Libya.
Etikar M; Department of Environment, Biotechnology Research Center (BTRC), Tripoli, Libya.

PLoS One ; 17(11): e0276425, 2022.

Article em En | MEDLINE | ID: mdl-36327290

Assuntos

COVID-19; Vacinas Virais; Adolescente; Humanos; Idoso; COVID-19/epidemiologia; COVID-19/prevenção & controle; SARS-CoV-2; Vacinas contra COVID-19/uso terapêutico; Estudos de Coortes; Líbia/epidemiologia; Estudos Retrospectivos; Vacinação; Hospitalização

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD / 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Vacinas Virais / COVID-19 Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Adolescent / Aged / Humans País/Região como assunto: Africa Idioma: En Revista: PLoS One Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google